Literature DB >> 3974686

A comparison of the treatment of rheumatoid arthritis in health maintenance organizations and fee-for-service practices.

E H Yelin, C J Henke, J S Kramer, M C Nevitt, M Shearn, W V Epstein.   

Abstract

This study compares the use of health care services (hospital and ambulatory) by patients with rheumatoid arthritis who were under the care of rheumatologists in prepaid and fee-for-service arrangements. Participating physicians from a random sample of half the rheumatologists in northern California maintained a log of all their patients with well-established diagnoses of rheumatoid arthritis. We interviewed 822 of their patients, using a structured, validated phone survey to obtain information about health care use. Patients in prepaid plans had about the same number and type of hospitalizations and the same rate of surgery as those receiving fee-for-service care. However, fee-for-service patients made more ambulatory visits. We conclude that the use of expensive services (hospital admissions and surgery) for the care of patients with rheumatoid arthritis is not different in fee-for-service and prepaid settings.

Entities:  

Mesh:

Year:  1985        PMID: 3974686     DOI: 10.1056/NEJM198504113121506

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  13 in total

Review 1.  International variation in resource utilisation and treatment costs for rheumatoid arthritis: a systematic literature review.

Authors:  Hubertus Rosery; Rito Bergemann; Stefanie Maxion-Bergemann
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  A brief history of medical taxonomy and diagnosis.

Authors:  Geza P Balint; W Watson Buchanan; Jan Dequeker
Journal:  Clin Rheumatol       Date:  2006-02-02       Impact factor: 2.980

3.  Family practitioners' intervention against smoking in Germany and the UK: does remuneration affect preventive activity?

Authors:  N Donner-Banzhoff; L Kreienbrock; E Baum
Journal:  Soz Praventivmed       Date:  1996

4.  A longitudinal study of hospitalization rates for patients with chronic disease: results from the Medical Outcomes Study.

Authors:  E C Nelson; C A McHorney; W G Manning; W H Rogers; M Zubkoff; S Greenfield; J E Ware; A R Tarlov
Journal:  Health Serv Res       Date:  1998-02       Impact factor: 3.402

5.  Sociodemographic, disease, health system, and contextual factors affecting the initiation of biologic agents in rheumatoid arthritis: a longitudinal study.

Authors:  Edward Yelin; Chris Tonner; Seoyoung C Kim; Jeffrey N Katz; John Z Ayanian; M Alan Brookhart; Daniel H Solomon
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-07       Impact factor: 4.794

Review 6.  A review of the direct costs of rheumatoid arthritis: managed care versus fee-for-service settings.

Authors:  D P Lubeck
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

7.  Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries.

Authors:  A Boonen; D van der Heijde; R Landewé; F Guillemin; M Rutten-van Mölken; M Dougados; H Mielants; K de Vlam; H van der Tempel; S Boesen; A Spoorenberg; H Schouten; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

8.  Impact of health maintenance organizations and fee-for-service on health care utilization among people with systemic lupus erythematosus.

Authors:  Edward Yelin; Laura Trupin; Patricia Katz; Lindsey A Criswell; Jinoos Yazdany; Joann Gillis; Peter Panopalis
Journal:  Arthritis Rheum       Date:  2007-04-15

9.  Patterns of psychosocial risk and long-term outcomes in rheumatoid arthritis.

Authors:  Anne Morris; Edward H Yelin; Belinda Wong; Patricia P Katz
Journal:  Psychol Health Med       Date:  2008-10       Impact factor: 2.423

10.  Predictors of stopping and starting disease-modifying antirheumatic drugs for rheumatoid arthritis.

Authors:  Daniel H Solomon; Chris Tonner; Bing Lu; Seoyoung C Kim; John Z Ayanian; M Alan Brookhart; Jeffrey N Katz; Ed Yelin
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-08       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.